(Press-News.org) Implementation in Massachusetts of a computer-automated safety surveillance system of clinical outcomes registries for cardiovascular devices resulted in the identification of a drug-releasing stent that had significantly higher rates of major adverse cardiac events than similar stents, according to a study in the November 10 issue of JAMA. The findings indicate that this type of system appears feasible and useful in identifying new cardiovascular devices with early low-frequency potential safety issues that are not observed in premarket approval studies.
"Monitoring the safety of approved medical products is of vital public health importance, given that in clinical practice such medical products are often used in numbers far greater and in patient populations more diverse than when studied in premarket evaluations and clinical trials," the authors write. "Ensuring the safety of medical devices challenges current surveillance approaches, which rely heavily on voluntary reporting of adverse events. Automated surveillance of clinical registries may provide early warnings in the postmarket evaluation of medical device safety."
Frederic S. Resnic, M.D., M.Sc., of Brigham and Women's Hospital and Harvard Medical School, Boston, and colleagues examined in-hospital safety signals for recently introduced cardiovascular devices using an automated safety surveillance system to assess the feasibility of such an approach to provide early warnings regarding their safety. The study included an analysis of seven newly introduced cardiovascular devices, using clinical data captured in the Massachusetts implementation of the National Cardiovascular Data Repository CathPCI Registry for all adult patients undergoing percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries) from April 2003 through September 2007 in Massachusetts. Patient, physician, and hospital data for 74,427 coronary interventional procedures performed during the study period were evaluated.
Of the 21 safety analyses performed, 3 (14 percent) generated a repeated or sustained safety signal involving 2 implanted devices, prompting detailed sensitivity analysis per study protocol. The safety alerts included an increased risk of postprocedural heart attack as well as an increased risk of major adverse cardiac events (MACE) following implantation of Taxus Express2 drug-releasing stents. By the end of the study period the rate of postprocedure heart attack was 27.6 percent higher for Taxus Express2 drug-releasing stents compared with alternative drug-releasing stents (2.87 percent vs. 2.25 percent; absolute risk increase, 0.62 percent). The rates of MACE were increased by 21.1 percent, driven by the increased postprocedural heart attack difference for the Taxus Express2 drug-releasing stent relative to the MACE rate for the control population (4.24 percent vs. 3.50 percent; absolute increase, 0.74 percent); and a sustained safety alert for MACE was triggered beginning in July 2007. No increased risk of death was observed among the exposure groups.
An increased rate of major vascular complications following implantation of the Angio-Seal STS vascular closure device was observed. By the end of the observation period, the matched subset of Angio-Seal STS case patients experienced a 51.3 percent increased risk of major vascular complications compared with the control population (1.09 percent vs. 0.72 percent; absolute increased risk, 0.37 percent).
Sensitivity analyses confirmed increased risk following use of the Taxus Express2 stent but not the Angio-Seal STS device.
"In conclusion, automated safety surveillance of medical devices is feasible using automated monitoring tools applied to detailed clinical registries and can efficiently help identify emerging potential postmarket safety risks. Automated medical product surveillance can complement existing public health strategies, providing an additional mechanism to assess the comparative safety of approved medical products and improve the quality of health care delivered," the authors write.
(JAMA. 2010;304[18]:2019-2027. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Editorial: Achieving Meaningful Device Surveillance
Gaps exist in the U.S. post-approval device surveillance safety net, according to John S. Rumsfeld, M.D., Ph.D., of the Veterans Affairs Medical Center, Denver, and University of Colorado, and Eric D. Peterson, M.D., M.P.H., of the Duke Clinical Research Institute and Duke University Medical Center, Durham, N.C., and Contributing Editor, JAMA, in an accompanying editorial.
"Beyond the specific findings, the study by Resnic et al represents an important advance in surveillance methodology. It principally supports the feasibility of automated monitoring for device safety signals. The report also demonstrates the value of using clinical registry data to ensure the appropriate level of detail of device, patient, and outcomes data for comparative safety analyses. In this case, the registry data are also used for public reporting of quality of care in Massachusetts; the data are highly complete and are audited. Furthermore, this investigation demonstrates the value of robust statistical methods in comparative safety evaluations using observational data, such as propensity matching and sensitivity analyses, supporting responsible interpretation of potential safety signals."
(JAMA. 2010;304[18]:2065-2066. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including financial disclosures, funding and support, etc.
To contact Frederic S. Resnic, M.D., M.Sc., call Kevin Myron at 617-534-1605 or email kmyron@partners.org. To contact editorial co-author John S. Rumsfeld, M.D., Ph.D., call Jacque Montgomery at 303-724-1528 or email Jacque.Montgomery@ucdenver.edu.
###For More Information: Contact the JAMA/Archives Media Relations Department at 312-464-JAMA or email: mediarelations@jama-archives.org.
In England, a country with a universal access health care system, there is wide variation between local populations in the rate of death from coronary heart disease, which is largely explained by population characteristics such as low socioeconomic factors, white ethnicity, levels of smoking, and diabetes, according to a study in the November 10 issue of JAMA.
"Although mortality from coronary heart disease (CHD) has been steadily decreasing since the 1970s, it is still responsible for 15 percent of all deaths and nearly half of all circulatory disease deaths in England. ...
The quality of public reporting of bloodstream infection rates among hospitals may be effected by the variation in surveillance methods, according to a study in the November 10 issue of JAMA.
"Public reporting of hospital-specific infection rates is widely promoted as a means to improve patient safety. Central line [central venous catheter]-associated bloodstream infection (BSI) rates are considered a key patient safety measure because such infections are frequent, lead to poor patient outcomes, are costly to the medical system, and are preventable. Publishing infection ...
DNA methylation plays an important role in many processes such as animal development, X-chromosome inactivation, and carcinogenesis. Understanding the mechanisms and functions of DNA methylation and how it varies from tissue to tissue and between individuals will have profound implications for human health and disease. A team of Chinese researchers decoded the essentially complete methylome (an inventory of all the bases that are methylated) of the human genome using peripheral blood mononuclear cells (PBMCs). The results will be published in the online, open access journal ...
Probiotic bacteria given as therapies for diarrhoea reduce the length of time sufferers are affected and lessen the chance of episodes continuing for more than four days. These are the findings of a new systematic review by Cochrane researchers.
Every year, diarrhoeal diseases kill nearly two million people in developing countries, mostly young children. The main treatment is rehydration fluids, but these do not tend to reduce the length of illness, which is crucial in reducing the risk of persistent diarrhoea. Probiotics, so-called "good bacteria", may help in a variety ...
Working to change the behaviour of family members may be an effective treatment for people with schizophrenia, according to a new Cochrane systematic review. The researchers reviewed the most up-to-date evidence on the subject and found that patients whose families received the interventions were less likely to relapse.
It has long been known that people who have schizophrenia are more likely to relapse if they come from families where they experience high levels of criticism, hostility and over involvement. New psychosocial interventions that aim to reduce levels of ...
A gene thought to be responsible for initiating human cancer has been identified by researchers at Barts and The London School of Medicine and Dentistry. The study - published online today (9 November) in the journal Cancer Research - paves the way for developing early cancer diagnostic tests, and finding new treatments that prevent or stop the spread of cancer cells at an early stage.
Led by Dr Muy-Tek Teh of the Institute of Dentistry at Barts and The London School of Medicine and Dentistry researchers have shown that a gene called FOXM1 exploits the inherent self-renewal ...
BOSTON, MA (Nov. 9, 2010) - With so few Americans consuming the recommended amounts of fruit each day, finding quick and simple ways to add additional fruit servings – and the important nutrients they provide – is more critical than ever. Although USDA recognizes that 4-oz of 100 percent juice supplies one serving (1/2 cup) of fruit, there is still confusion regarding the healthfulness of juice. New research presented today at the American Dietetic Association (ADA) Annual Food and Nutrition Conference and Expo (FNCE) clearly highlights the benefits of 100 percent juice, ...
CLEVELAND – November 9, 2010—Texting while driving can be a deadly combination for anyone. Yet, new data released today reveal that the dangers of excessive texting among teens are not limited to the road. Hyper-texting and hyper-networking are now giving rise to a new health risk category for this age group.
Scott Frank, MD, MS, lead researcher on the study and director of the Case Western Reserve School of Medicine Master of Public Health program, presented the findings today at the American Public Health Association's 138th Annual Meeting & Exposition in Denver. Researchers ...
Young children who don't like school are more likely to be involved in underage drinking and sexual activity. A study reported in BioMed Central's open access journal Substance Abuse, Treatment, Prevention and Policy, has found that pupils' general wellbeing and specific satisfaction with school were both associated with the incidence of risky behaviors.
Professor Mark Bellis worked with a team of researchers from the Centre for Public Health, Liverpool John Moores University, to carry out the study in more than 3500 11-14 year olds from 15 schools in the North West of ...
While policy and research traditionally have focused on universities' contributions to technology transfer - such as patents, licences and spin-outs - the findings show that the impact from knowledge exchange is much more wide-ranging. Survey data revealed that business motivations to enter into partnerships with researchers include service development, human resource management, training and marketing.
"Our findings show that technology transfer is important, but this presents an incomplete representation of the wide process of knowledge exchange that takes place between ...
